Evidence map›Paper›PMID 35907085›Full record

ArticleClinical journal of gastroenterology2022

Dramatic disappearance of hyperglycemia and abnormal neurologic symptoms after resection of duodenal gastrointestinal stromal tumor.

Thitiporn Wannasri, Vor Luvira, Chawalit Pairojkul

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Clinical journal of gastroenterology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Thitiporn WannasriDepartment of Surgery, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Vor LuviraDepartment of Surgery, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand. vor_110@yahoo.com.ORCID http://orcid.org/0000-0001-7333-2936
Chawalit PairojkulDepartment of Pathology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Khon Kaen University · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastrointestinal stromal tumor (GIST) is a common mesenchymal neoplasm of the gastrointestinal (GI) tract. Paraneoplastic syndromes of GISTs are rare; in particular, GIST-induced hyperglycemia has not been reported. A 67-year-old woman presented with recurrent alteration of consciousness and uncontrolled hyperglycemia. Computed tomography scans showed a huge hypervascular mass, located medial to the superior mesenteric vessels. Endoscopic ultrasonography (EUS) with fine-needle aspiration (FNA) showed spindle cell tumors, diagnosed as borderline resectable duodenal GIST. There was partial response after 6 months of Imatinib treatment. En-bloc resection was performed via the laparotomy. The histology confirmed a high-risk GIST at the third part of the duodenum. The abnormal symptoms then dramatically disappeared. She has remained recurrence free for 22 months. Uncontrolled hyperglycemia and abnormal neurological conditions are rare in GIST; however, a large hypervascular GIST could cause paraneoplastic syndromes or consume the products from an adjacent structure, requiring complete tumor resection. This case adds the knowledge of an extremely rare presentation of GIST and, moreover, extremely rare cause of uncontrolled hyperglycemia.

Indexed as

Gastrointestinal Stromal TumorsHyperglycemiaParaneoplastic SyndromesAgedDuodenumFemaleHumansImatinib MesylateImatinib MesylateGastrointestinal stromal tumorGISTHyperglycemiaParaneoplastic syndromes

Identifiers

PMID35907085
OpenAlexW4288758256

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.